Xolair 150 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DB25FEQCU
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $4,642
Award facts
- Contract value 100% obligated
- $4,642.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $4,642.20 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Xolair 150 mg/ml syringes. The contract, issued on August 21, 2025, with an ultimate completion date of September 12, 2025, operates under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at approximately $500 million through November 2026. No set-aside designation was applied to this specific delivery order, allowing the contractor to compete on an unrestricted basis. The place of performance is located in Park Ridge, Illinois.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently delivering specialized pharmaceutical products to Department of Defense healthcare facilities nationwide. This delivery order for Xolair, a biologic medication used in respiratory and allergic conditions, exemplifies the company's role in supporting military medical readiness by providing essential pharmaceutical inventory to federal healthcare systems. The firm fixed-price structure ensures cost predictability for the government while leveraging the contractor's existing supply chain capabilities under the overarching DLA pharmaceutical supply contract.
Quick answers
Who was awarded contract SPE2DB25FEQCU?
SPE2DB25FEQCU was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FEQCU worth?
The government has obligated $4,642 on SPE2DB25FEQCU.
Is contract SPE2DB25FEQCU an order under another contract?
Yes. SPE2DB25FEQCU is a delivery order under SPE2DB24D9113, an indefinite delivery contract.
Was contract SPE2DB25FEQCU competed?
The extent of competition for SPE2DB25FEQCU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award